Skip to main content

Vertex Pharmaceuticals Inc

VRTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000875320

In the last 90 days, Vertex Pharmaceuticals Inc insiders filed 0 open-market purchases and 4 sales; 1,763 institutions reported holding it in 13F filings for Q2 2026, worth $120.1B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Vertex Pharmaceuticals Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
4 filings
4 insiders, $2.29M in total
Insiders trading
4
Net value
−$2.29M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Vertex Pharmaceuticals Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Vertex Pharmaceuticals Inc
NameTitleLast reported holdingLast filingFilings, past year
van Grunsven JasperEVP, CP and NPPO8,682Sep 10, 20261
Ambrose KristenSVP & Chief Accounting Officer11,624Sep 1, 20267
Sachs Bruce IDirector39,000Aug 31, 20266
Tatsis OuraniaEVP, Chief Reg. & Quality Off.53,572Jul 23, 20269
Sachdev AmitEVP Chief Patient & Ext Af Off66,512Jul 23, 20267
Garber Alan MDirector7,344Jul 17, 20263
McKechnie DuncanEVP, Chief Commercial Officer11,001Jul 7, 20268
Liu JoyEVP and Chief Legal Officer19,131Jul 6, 20265
Bozic CarmenEVP and CMO15,337Jun 30, 202615
Bunnage Mark E.EVP, Chief Scientific Officer7,284May 19, 20265
Carney LloydDirector6,315May 5, 20262
Lagarde MichelDirector1,132May 5, 20261
Upadhyay SuketuDirector1,558May 5, 20264
Bhatia Sangeeta N.Director4,924May 5, 20262
McKenzie DianaDirector2,378May 5, 20261
Schneider JenniferDirector1,394May 5, 20261
Thornberry NancyDirector2,109May 5, 20261
Kewalramani ReshmaCEO & President98,278Mar 3, 20266
Wagner Charles F JrEVP, CO & FO47,042Feb 26, 20267
Leiden Jeffrey MExecutive Chairman34,797Feb 26, 20265
Biller JonathanEVP and Chief Legal Officer13,659Feb 26, 20267
Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.18,432Feb 26, 20266
Altshuler DavidEVP, Chief Scientific Officer34,477Jan 26, 20261
Arbuckle Stuart AEVP, COO63,368Jul 2, 20250
Kearney Terrence CDirector6,536May 3, 20240
Sanna BastianoEVP, Cell & Genetic Therapies32,038May 9, 20230
McGlynn Margaret GDirector178May 3, 20230
Lee YuchunDirector1,875May 3, 20230

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 7, 2026 (view filing)4:15 PM ETJul 25 daysTatsis OuraniaEVP, Chief Reg. & Quality Off.SSale−1.50K$524.99−$787.5K−3.2%45.3K after10b5-1
Jul 7, 2026 (view filing)4:08 PM ETJul 25 daysMcKechnie DuncanEVP, Chief Commercial OfficerSSale−1.54K$519.00−$799.8K−12.3%11.0K after10b5-1
Jul 6, 2026 (view filing)4:13 PM ETJul 15 daysLiu JoyEVP and Chief Legal OfficerSSale−828$502.71−$416.2K−4.1%19.1K after10b5-1
Jun 30, 2026 (view filing)Jun 264 daysBozic CarmenEVP and CMOSSale−596$482.50−$287.6K−3.7%15.3K after10b5-1
Jun 23, 2026 (view filing)Jun 185 daysBozic CarmenEVP and CMOSSale−1.02K$462.17−$471.4K−6.0%15.9K after10b5-1
Jun 17, 2026 (view filing)Jun 152 daysBozic CarmenEVP and CMOSSale−4.06K$450.00−$1.83M−19.3%17.0K after10b5-1
Jun 9, 2026 (view filing)Jun 54 daysBozic CarmenEVP and CMOSSale−1.75K$450.00−$785.3K−7.7%21.0K after10b5-1
Jun 3, 2026 (view filing)Jun 12 daysLiu JoyEVP and Chief Legal OfficerSSale−828$439.91−$364.2K−4.0%20.0K after10b5-1
Jun 2, 2026 (view filing)May 294 daysBozic CarmenEVP and CMOSSale−1.97K$450.00−$888.3K−8.0%22.8K after10b5-1
May 19, 2026 (view filing)May 154 daysBunnage Mark E.EVP, Chief Scientific OfficerSSale−33$453.45−$15.0K−0.5%7.28K after10b5-1
May 19, 2026 (view filing)May 154 daysBozic CarmenEVP and CMOSSale−1.35K$453.45−$614.0K−5.2%24.7K after10b5-1
May 14, 2026 (view filing)May 122 daysBozic CarmenEVP and CMOSSale−6.99K$450.00−$3.14M−21.1%26.1K after10b5-1
May 5, 2026 (view filing)May 14 daysLiu JoyEVP and Chief Legal OfficerSSale−1.10K$425.02−$469.2K−5.1%20.7K after10b5-1
May 5, 2026 (view filing)May 41 dayBhatia Sangeeta N.DirectorSSale−318$423.73−$134.7K−6.1%4.92K after10b5-1
Apr 3, 2026 (view filing)Apr 12 daysLiu JoyEVP and Chief Legal OfficerSSale−978$449.17−$439.3K−4.3%21.8K after10b5-1
Mar 31, 2026 (view filing)Mar 274 daysBozic CarmenEVP and CMOSSale−2.33K$450.95−$1.05M−6.6%33.1K after10b5-1
Mar 17, 2026 (view filing)Mar 134 daysBozic CarmenEVP and CMOSSale−2.33K$481.79−$1.12M−6.2%35.4K after10b5-1
Mar 13, 2026 (view filing)Mar 112 daysMcKechnie DuncanEVP, Chief Commercial OfficerSSale−2.63K$498.42−$1.31M−17.4%12.5K after10b5-1
Mar 6, 2026 (view filing)Mar 42 daysMcKechnie DuncanEVP, Chief Commercial OfficerSSale−2.44K$475.30−$1.16M−13.9%15.1K after10b5-1
Mar 4, 2026 (view filing)Mar 22 daysLiu JoyEVP and Chief Legal OfficerSSale−892$495.96−$442.4K−3.8%22.8K after10b5-1
Mar 3, 2026 (view filing)Feb 274 daysKewalramani ReshmaCEO & PresidentSSale−40.0K$493.47−$19.7M−28.9%98.3K after13 lots10b5-1
Mar 3, 2026 (view filing)Feb 274 daysBozic CarmenEVP and CMOSSale−2.33K$480.31−$1.12M−5.8%37.7K after10b5-1
Mar 2, 2026 (view filing)Feb 264 daysAmbrose KristenSVP & Chief Accounting OfficerSSale−357$483.36−$172.6K−5.1%6.62K after10b5-1
Feb 26, 2026 (view filing)Feb 251 dayTatsis OuraniaEVP, Chief Reg. & Quality Off.SSale−260$486.35−$126.5K−0.6%46.8K after10b5-1
Feb 26, 2026 (view filing)Feb 251 daySachdev AmitEVP Chief Patient & Ext Af OffSSale−1.85K$486.35−$897.8K−3.2%55.6K after10b5-1
Feb 26, 2026 (view filing)Feb 251 dayMcKechnie DuncanEVP, Chief Commercial OfficerSSale−4.91K$487.65−$2.39M−21.9%17.6K after2 lots10b5-1
Feb 26, 2026 (view filing)Feb 251 dayBunnage Mark E.EVP, Chief Scientific OfficerSSale−620$486.35−$301.5K−7.8%7.28K after10b5-1
Feb 26, 2026 (view filing)Feb 251 dayBiller JonathanEVP and Chief Legal OfficerSSale−945$486.35−$459.6K−6.5%13.7K after10b5-1
Feb 26, 2026 (view filing)Feb 251 dayAtkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.SSale−668$486.35−$324.9K−3.5%18.4K after10b5-1
Feb 26, 2026 (view filing)Feb 251 dayAmbrose KristenSVP & Chief Accounting OfficerSSale−223$486.35−$108.5K−3.1%6.98K after10b5-1
Feb 23, 2026 (view filing)Feb 194 daysSachdev AmitEVP Chief Patient & Ext Af OffSSale−58.6K$468.83−$27.5M−49.9%58.9K after8 lots10b5-1
Feb 19, 2026 (view filing)Feb 17-182 daysTatsis OuraniaEVP, Chief Reg. & Quality Off.SSale−977$483.52−$472.4K−2.0%48.6K after2 lots10b5-1
Feb 19, 2026 (view filing)Feb 17-182 daysBunnage Mark E.EVP, Chief Scientific OfficerSSale−3.62K$484.31−$1.75M−29.9%8.49K after2 lots10b5-1
Feb 19, 2026 (view filing)Feb 17-182 daysBiller JonathanEVP and Chief Legal OfficerSSale−3.72K$484.18−$1.80M−19.1%15.7K after2 lots10b5-1
Feb 19, 2026 (view filing)Feb 17-182 daysAtkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.SSale−2.85K$484.93−$1.38M−12.1%20.7K after2 lots10b5-1
Feb 19, 2026 (view filing)Feb 17-182 daysAmbrose KristenSVP & Chief Accounting OfficerSSale−2.19K$484.87−$1.06M−22.1%7.75K after2 lots10b5-1
Feb 18, 2026 (view filing)Feb 135 daysTatsis OuraniaEVP, Chief Reg. & Quality Off.SSale−1.50K$499.99−$750.0K−3.1%46.1K after10b5-1
Feb 18, 2026 (view filing)Feb 135 daysBiller JonathanEVP and Chief Legal OfficerSSale−988$499.00−$493.0K−5.5%16.8K after10b5-1
Feb 18, 2026 (view filing)Feb 135 daysBhatia Sangeeta N.DirectorSSale−266$500.00−$133.0K−5.8%4.30K after10b5-1
Feb 12, 2026 (view filing)Feb 111 dayTatsis OuraniaEVP, Chief Reg. & Quality Off.SSale−466$460.43−$214.6K−0.9%51.4K after10b5-1
Feb 12, 2026 (view filing)Feb 111 dayBunnage Mark E.EVP, Chief Scientific OfficerSSale−2.02K$460.43−$930.5K−13.5%12.9K after10b5-1
Feb 12, 2026 (view filing)Feb 111 dayBiller JonathanEVP and Chief Legal OfficerSSale−1.93K$460.43−$886.3K−8.5%20.8K after10b5-1
Feb 12, 2026 (view filing)Feb 111 dayAtkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.SSale−1.75K$460.43−$806.2K−7.4%22.0K after10b5-1
Feb 12, 2026 (view filing)Feb 111 dayAmbrose KristenSVP & Chief Accounting OfficerSSale−1.38K$460.43−$633.6K−12.0%10.1K after10b5-1
Jan 9, 2026 (view filing)Jan 72 daysTatsis OuraniaEVP, Chief Reg. & Quality Off.SSale−4.50K$474.99−$2.14M−9.6%42.3K after10b5-1
Jan 8, 2026 (view filing)Jan 62 daysWagner Charles F JrEVP, CO & FOSSale−9.53K$461.00−$4.39M−20.2%37.7K after10b5-1
Dec 5, 2025 (view filing)Dec 32 daysWagner Charles F JrEVP, CO & FOSSale−14.0K$456.00−$6.38M−27.1%37.7K after2 lots10b5-1
Dec 5, 2025 (view filing)Dec 32 daysTatsis OuraniaEVP, Chief Reg. & Quality Off.SSale−4.50K$449.99−$2.02M−8.8%46.8K after10b5-1
Dec 5, 2025 (view filing)Dec 32 daysLeiden Jeffrey MExecutive ChairmanSSale−63.8K$449.20−$28.7M−72.6%24.0K after12 lots10b5-1
Dec 5, 2025 (view filing)Dec 32 daysBiller JonathanEVP and Chief Legal OfficerSSale−347$449.00−$155.8K−2.2%15.3K after10b5-1